SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A,
BIB 83.68+0.1%Nov 28 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jibacoa who wrote (1246)7/20/2005 11:47:01 AM
From: Jibacoa  Read Replies (2) of 3722
 
MLNM Opened with an upgap and had good upvolume in the first few minutes of trading. It seems it may get to test its January 14H at 11,42 in the near future, but it first needs to go over its intraday double top at 10.59AM-11.02AM at the 10,50 level.<g>(The stock is now trying to find support at 10.38 <g>)

As previously mentioned, last Monday it announced that it was starting a PII of MLN1202, its humanized monoclonal antibody, in patients with relapsing-remitting MS

MLN1202 is supposed to block CCR2 chemokine receptors and to prevent the infiltration of immune cells into inflammatory sites.

MLNM Reportedly has around $1.85 in cash/shr and is expected to cut its loss to $0.35/shr vs. $0.59 in 2004 and for 2006 a further cut is expected to $0.07/shr.<g>

Bernard

P.S. There was a 563,818 downtick at 11.47AMfrom 10.40 to 10.36 albeit it recovered some since then on low volume,g>
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext